2026-01-102026-01-102024-03-11https://repos.sumathipublications.com:8000/handle/123456789/274Nanomedicine stands at the forefront of healthcare advancements, leveraging nanotechnology to enhance diagnosis, treatment, and disease prevention. Within this rapidly growing field, nanoparticles exhibit unique traits, such as a notable surface area-to-volume ratio and precise targeting abilities, making them valuable in medical applications. The article delves into diverse types of nanomedicines utilized in the pharmaceutical sector, exploring their potential advantages and examining targeted drug delivery mechanisms. Key breakthroughs, like globally recognized therapies such as Doxil and Abraxane, have emerged from nanomedicine. However, it emphasizes the necessity to address regulatory and ethical considerations to ensure both safety and efficacy. The article sheds light on limitations in targeted drug delivery, including issues like limited drug payload capacity and a lack of specificity, emphasizing the importance of addressing these challenges. Despite hurdles, the future of nanomedicine appears promising, poised to revolutionize personalized medicine, elevate disease detection and treatment, and support tissue regeneration and repair. Integration with artificial intelligence is highlighted as a potential avenue for achieving more precise and efficient drug delivery and disease diagnosis. The article underscores the significance of ongoing investments and collaborations among researchers, healthcare providers, and industry partners to surmount obstacles and unlock the full potential of nanomedicine. In conclusion, nanomedicine stands as a dynamic and promising field with the potential to bring about significant improvements in healthcare outcomes. Keywords: Nanomedicine, Targeted drug delivery system, Treatment, Healthcare, FDA (food and drug administration).application/pdftext/xmlCopyright (c) 2024 Ramdas Bhat, Himasvi MM, Varshini N, AR SHABARAYAhttp://creativecommons.org/licenses/by-nc-sa/4.0NanomedicineTargeted drug delivery systemTreatmentHealthcareFDA (food and drug administration)info:eu-repo/semantics/article